相关实验视频
Updated: Jan 13, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
901
关于儿童和青少年抗肥胖药物的最新情况
Mostafa Salama1,2, Doha Hassan1, Seema Kumar1,2
1Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA.
Children (Basel, Switzerland)
|October 29, 2025
概括
儿童肥胖是一个日益蔓延的流行病. 本综述考察了儿童和青少年的抗肥胖药物,并提供了基于年龄的有效管理策略,以及生活方式的改变.
科学领域:
- 儿科 儿科 儿科
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 儿童肥胖是一个复杂的流行病,带有重大健康风险.
- 生活方式的改变提供了适度的结果,需要药理干预.
- 目前对年幼儿童的药理选择有限.
研究的目的:
- 审查儿童群体中抗肥胖药物的疗效和安全性.
- 为这些药物的临床使用提供基于年龄的策略.
- 为了指导全面的肥胖管理计划.
主要方法:
- 对抗肥胖药物的现有证据进行系统审查.
- 对儿童和青少年的疗效和安全数据的分析.
- 制定实用,年龄分层的治疗指南.
主要成果:
- 葡萄糖类-1 (GLP-1) 受体激活剂在青少年中显示出有前途.
- 对于年幼的儿童,药理选择有限.
- 综合管理计划对于成功的结果至关重要.
结论:
- 药物治疗是重症或耐药儿科肥胖症的重要辅助.
- 为了最佳的药物使用,需要适合年龄的策略.
- 为了有效治疗年幼儿童,需要进一步的研究.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Antidepressant Drugs: MAOIs and Other Agents
797
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
797
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
581
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
581

